Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Ann Rheum Dis ; 67(4): 536-41, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17644548

RESUMEN

OBJECTIVE: To develop evidence-based recommendations for the management of fibromyalgia syndrome. METHODS: A multidisciplinary task force was formed representing 11 European countries. The design of the study, including search strategy, participants, interventions, outcome measures, data collection and analytical method, was defined at the outset. A systematic review was undertaken with the keywords "fibromyalgia", "treatment or management" and "trial". Studies were excluded if they did not utilise the American College of Rheumatology classification criteria, were not clinical trials, or included patients with chronic fatigue syndrome or myalgic encephalomyelitis. Primary outcome measures were change in pain assessed by visual analogue scale and fibromyalgia impact questionnaire. The quality of the studies was categorised based on randomisation, blinding and allocation concealment. Only the highest quality studies were used to base recommendations on. When there was insufficient evidence from the literature, a Delphi process was used to provide basis for recommendation. RESULTS: 146 studies were eligible for the review. 39 pharmacological intervention studies and 59 non-pharmacological were included in the final recommendation summary tables once those of a lower quality or with insufficient data were separated. The categories of treatment identified were antidepressants, analgesics, and "other pharmacological" and exercise, cognitive behavioural therapy, education, dietary interventions and "other non-pharmacological". In many studies sample size was small and the quality of the study was insufficient for strong recommendations to be made. CONCLUSIONS: Nine recommendations for the management of fibromyalgia syndrome were developed using a systematic review and expert consensus.


Asunto(s)
Fibromialgia/terapia , Analgésicos Opioides/uso terapéutico , Antidepresivos/uso terapéutico , Balneología , Medicina Basada en la Evidencia , Humanos , Proyectos de Investigación , Tramadol/uso terapéutico
3.
J Intern Med ; 228(6): 577-81, 1990 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-2177768

RESUMEN

Fifteen patients with myotonic dystrophy, seven men and eight women, of age range 15-55 years, were treated with sodium selenite and vitamin E for 2 years. The patients were examined using a number of tests to assess muscle force and function at the start of the treatment period and 6, 12 and 24 months thereafter. Myotonia gives an increased relaxation time. The latter was measured in the adductor pollicis. There was a significant decrease in half relaxation time before treatment compared with the values during treatment. In summary, the results indicate that selenium and vitamin E therapy may have an effect on myotonia. The effects of treatment on motor functions were minimal, and overall motor performance was not improved.


Asunto(s)
Contracción Muscular/efectos de los fármacos , Distrofia Miotónica/tratamiento farmacológico , Selenio/uso terapéutico , Vitamina E/uso terapéutico , Adulto , Femenino , Marcha/fisiología , Humanos , Masculino , Distrofia Miotónica/fisiopatología , Resistencia Física/fisiología , Carrera , Selenito de Sodio , Factores de Tiempo
4.
Acta Neurol Scand ; 78(5): 429-35, 1988 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-3218450

RESUMEN

16 boys with Duchenne muscular dystrophy (DMD) were treated with sodium selenite and vitamin E for one year. One group of patients (10 boys) was examined using a battery of tests to assess muscular strength and function and cardiopulmonary function, and by CT scanning of 2 muscle groups over the 4 years prior to treatment. Six boys with DMD entered the study when the treatment was begun. Tests of muscular force and function, cardiopulmonary tests and CT-scanning were performed at the onset of treatment, and after 6 and 12 months. No beneficial effect on either muscular force or function was found during the treatment period. It is concluded that selenium and vitamin E in high doses do not improve muscle function in DMD.


Asunto(s)
Músculos/fisiopatología , Distrofias Musculares/tratamiento farmacológico , Selenio/uso terapéutico , Vitamina E/uso terapéutico , Adolescente , Niño , Humanos , Masculino , Distrofias Musculares/fisiopatología
5.
Artículo en Inglés | MEDLINE | ID: mdl-3387922

RESUMEN

In the post-ischemic muscle, hyperbaric oxygen (HBO) treatments have been shown to reduce post-ischemic edema and enhance aerobic metabolism. In the present paper histological, histochemical and ultrastructural methods were used to study the influences of HBO treatment on the morphology of post-ischemic skeletal muscle. The changes were also quantified using morphometry. The circulation of the rat hindlimb was interrupted for 3 hours and muscle biopsies were taken 5 and 12 hours post-ischemia. Light microscopy showed signs of ischemic changes in the muscle. Morphometrically, the area with activity of the muscle enzyme phosphorylase was greatly reduced post-ischemia. HBO treatment at 2.5 atmospheres of absolute pressure (ATA) for 45 min significantly increased muscle cross sectional area with a positive phosphorylase reaction 5 hours post-ischemia. Three HBO treatments were necessary to maintain this effect, 12 hours post-ischemia. Ultrastructurally, the ischemic changes seen using light microscopy were confirmed. Morphometrically, there was a significant increase of mitochondrial size in the ischemic muscle compared with the control uninjured muscle but HBO did not markedly reduce these ultrastructural changes. It was concluded that the reduction of phosphorylase activity, a sensitive marker for muscle cell damage, is to a great extent prevented by HBO treatment in the post-ischemic phase.


Asunto(s)
Oxigenoterapia Hiperbárica , Isquemia/terapia , Músculos/irrigación sanguínea , Animales , Dihidrolipoamida Deshidrogenasa/metabolismo , Isquemia/enzimología , Isquemia/patología , Masculino , Mitocondrias Musculares/ultraestructura , Músculos/enzimología , Músculos/ultraestructura , Fosforilasas/metabolismo , Ratas , Ratas Endogámicas
6.
Scand J Rehabil Med ; 17(4): 191-6, 1985.
Artículo en Inglés | MEDLINE | ID: mdl-3936168

RESUMEN

Adolescent patients with idiopathic scoliosis were treated with long-term electrical stimulation (30 Hz) at the posterior axillary line on the convex side of the curvature in order to correct the spinal deformity. The patients were also followed with muscle biopsies from the latissimus dorsi of the stimulated side taken before, after 3 and 6 months of electrical stimulation. There was a tendency for an increase in the percentage of type I and especially the type II C (undifferentiated) fibers after stimulation. The mean muscle fiber area and the fiber areas of the various fiber types did not change significantly. Histopathological findings were generally rare before as well as after 3 months of electrical stimulation, the only noticeable finding being a somewhat increased frequency of atrophic fibers in groups after 6 months of stimulation. In all studied patients the enzymatic activity of citrate synthase increased after 3 months and further in three studied patients after 6 months of stimulation. The present study gives some evidence of an adaptive process caused by electrical stimulation towards a more fatigue-resistant muscle.


Asunto(s)
Terapia por Estimulación Eléctrica , Enzimas/metabolismo , Músculos/patología , Escoliosis/terapia , Adenilato Quinasa/metabolismo , Biopsia , Niño , Citrato (si)-Sintasa/metabolismo , Femenino , Gliceraldehído-3-Fosfato Deshidrogenasas/metabolismo , Glucógeno/metabolismo , Humanos , L-Lactato Deshidrogenasa/metabolismo , Cuidados a Largo Plazo , Masculino , Proteínas Musculares/metabolismo , Escoliosis/enzimología , Escoliosis/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA